Catalyst Pharmaceuticals Quarterly Balance Sheets Chart
Quarterly
|
Annual
Catalyst Pharmaceuticals Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2016-12-31 | 2016-12-15 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2012-09-30 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 652,800,000 | 580,656,000 | 517,553,000 | 442,331,000 | 375,693,000 | 310,411,000 | 137,636,000 | 120,971,000 | 178,787,000 | 148,247,000 | 298,395,000 | 256,065,000 | 210,912,000 | 178,372,000 | 171,445,000 | 154,836,000 | 135,295,000 | 127,328,000 | 130,237,109 | 117,105,973 | 115,052,248 | 101,750,937 | 89,511,710 | 44,983,218 | 23,417,512 | 19,081,714 | 16,559,400 | 10,616,313 | 9,887,939 | 19,600,591 | 57,496,702 | 7,328,984 | 13,893,064 | 28,235,016 | 9,096,778 | 2,215,958 | 1,409,939 | 11,973,860 | 6,029,067 | 5,475,158 | 7,779,277 | 11,766,629 | 15,027,447 | 13,084,108 | 14,716,512 | 16,886,194 | 17,600,170 | 19,064,940 | 20,434,702 | 3,003,436 | |
| accounts receivable | 65,863,000 | 71,265,000 | 65,476,000 | 58,266,000 | 57,172,000 | 60,493,000 | 53,514,000 | 48,049,000 | 42,796,000 | 33,402,000 | 10,439,000 | 9,337,000 | 9,587,000 | 10,552,000 | 6,619,000 | 6,625,000 | 6,292,000 | 5,601,000 | 5,987,426 | 5,871,893 | 6,762,262 | 6,918,563 | 10,536,997 | 10,095,352 | 10,376,427 | 7,251,381 | |||||||||||||||||||||||||
| inventory | 18,650,000 | 19,778,000 | 19,541,000 | 20,017,000 | 18,014,000 | 19,953,000 | 15,644,000 | 9,035,000 | 10,751,000 | 10,328,000 | 6,805,000 | 7,132,000 | 7,850,000 | 7,827,000 | 7,870,000 | 6,950,000 | 7,097,000 | 4,390,000 | 4,650,600 | 4,747,538 | 1,827,924 | 2,211,338 | 1,956,792 | 599,801 | 269,879 | 96,587 | 56,012 | ||||||||||||||||||||||||
| prepaid expenses and other current assets | 21,426,000 | 14,019,000 | 21,039,000 | 18,384,000 | 23,550,000 | 13,745,000 | 12,535,000 | 13,962,000 | 8,634,000 | 6,934,000 | 5,158,000 | 3,776,000 | 4,333,000 | 5,016,000 | 4,351,000 | 4,428,000 | 7,641,000 | 8,243,000 | 8,327,771 | 5,614,052 | 7,521,253 | 6,062,715 | 4,351,074 | 3,339,399 | 1,488,603 | 1,881,266 | 1,649,781 | 816,820 | 677,341 | 992,828 | 1,173,744 | 510,492 | 1,047,944 | 1,504,738 | 4,552,698 | ||||||||||||||||
| total current assets | 758,739,000 | 685,718,000 | 623,609,000 | 538,998,000 | 474,429,000 | 404,602,000 | 219,329,000 | 192,017,000 | 240,968,000 | 198,911,000 | 320,797,000 | 276,310,000 | 242,558,000 | 221,191,000 | 210,106,000 | 192,795,000 | 176,305,000 | 161,533,000 | 159,243,974 | 143,342,205 | 131,163,687 | 116,943,553 | 111,363,623 | 90,579,443 | 72,055,863 | 54,862,012 | 55,187,406 | 62,480,975 | 69,086,236 | 78,935,997 | 85,187,157 | 34,416,977 | 41,453,761 | 59,901,133 | 43,827,821 | 25,320,038 | 16,726,678 | 6,228,183 | 5,775,404 | 7,887,424 | 11,915,156 | 15,217,974 | 13,396,593 | 15,342,864 | 17,447,584 | 18,176,853 | 19,335,975 | 3,006,661 | |||
| operating lease right-of-use asset | 2,084,000 | 2,158,000 | 2,230,000 | 2,301,000 | 2,371,000 | 2,440,000 | 2,508,000 | 2,575,000 | 2,641,000 | 2,706,000 | 2,770,000 | 2,833,000 | 2,895,000 | 2,957,000 | 3,017,000 | 3,093,000 | 3,201,000 | 3,309,000 | 12,167 | 71,711 | 730,284 | 793,252 | 952,340 | 1,013,590 | 1,074,020 | ||||||||||||||||||||||||||
| property and equipment | 1,149,000 | 1,239,000 | 1,354,000 | 1,380,000 | 1,227,000 | 1,308,000 | 1,195,000 | 1,186,000 | 1,203,000 | 1,285,000 | 847,000 | 882,000 | 917,000 | 925,000 | 959,000 | 951,000 | 914,000 | 944,000 | 129,800 | 149,119 | 167,514 | 196,926 | 210,467 | 141,088 | 147,619 | 140,320 | 245,425 | 201,093 | 187,131 | 183,370 | 191,385 | 205,450 | 244,204 | 191,549 | 71,377 | 40,628 | 53,679 | 12,186 | 45,573 | 68,447 | 96,376 | 104,535 | 112,694 | 120,926 | 125,517 | 49,555 | 22,180 | 19,717 | |||
| license and acquired intangibles | 137,983,000 | 147,327,000 | 156,672,000 | 166,016,000 | 175,361,000 | 184,705,000 | 194,049,000 | 167,108,000 | 175,595,000 | 184,083,000 | 32,471,000 | 33,051,000 | |||||||||||||||||||||||||||||||||||||||
| deferred tax assets | 50,704,000 | 48,222,000 | 45,982,000 | 48,473,000 | 39,889,000 | 38,276,000 | 36,544,000 | 37,428,000 | 23,489,000 | 20,242,000 | 18,736,000 | 20,029,000 | 20,930,000 | 21,890,000 | 23,697,000 | 26,400,000 | 28,701,000 | 31,421,000 | 32,971,264 | 31,347,442 | |||||||||||||||||||||||||||||||
| investment in equity securities | 21,256,000 | 24,208,000 | 21,564,000 | 14,842,000 | 13,083,000 | 15,345,000 | 16,489,000 | 12,897,000 | |||||||||||||||||||||||||||||||||||||||||||
| total assets | 971,915,000 | 908,872,000 | 851,411,000 | 772,010,000 | 706,360,000 | 646,676,000 | 470,114,000 | 413,211,000 | 443,896,000 | 407,227,000 | 375,630,000 | 333,114,000 | 267,309,000 | 246,972,000 | 237,788,000 | 223,248,000 | 209,130,000 | 197,216,000 | 192,353,926 | 174,859,821 | 131,411,800 | 117,879,651 | 112,376,230 | 96,690,559 | 78,234,360 | 61,076,840 | 60,449,962 | 67,709,813 | 74,287,576 | 79,128,255 | 85,387,430 | 34,631,315 | 41,706,853 | 60,101,570 | 43,908,086 | 25,369,554 | 16,789,245 | 6,249,257 | 5,831,488 | 7,966,382 | 12,032,968 | 15,347,957 | 13,534,735 | 15,489,238 | 17,593,489 | 18,246,796 | 19,378,543 | 20,619,479 | 3,512,007 | ||
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 5,528,000 | 11,197,000 | 16,593,000 | 11,563,000 | 7,116,000 | 10,261,000 | 14,795,000 | 4,598,000 | 4,421,000 | 3,391,000 | 3,975,000 | 2,529,000 | 2,315,000 | 5,139,000 | 2,768,000 | 2,752,000 | 2,924,000 | 2,561,000 | 4,256,020 | 2,005,340 | 5,804,778 | 1,347,577 | 4,117,447 | 4,147,029 | 3,328,726 | 2,940,086 | 2,337,367 | 1,340,984 | 922,593 | 805,023 | 1,945,575 | 1,081,608 | 933,176 | 1,794,127 | 1,814,210 | 850,789 | 1,365,663 | 263,934 | 105,933 | 249,635 | 332,707 | 635,633 | 181,276 | 316,578 | 229,478 | 146,383 | 312,465 | 417,754 | |||
| accrued expenses and other liabilities | 107,479,000 | 100,452,000 | 104,085,000 | 93,832,000 | 85,202,000 | 69,305,000 | 61,268,000 | 53,208,000 | 48,082,000 | 53,318,000 | 53,613,000 | 42,152,000 | 20,173,000 | 17,799,000 | 24,295,000 | 17,862,000 | 13,211,000 | 11,875,000 | 18,500,267 | 16,226,609 | 14,405,597 | 16,287,936 | 19,981,295 | 13,835,292 | 10,822,803 | 6,086,029 | 7,173,987 | 2,127,450 | 2,159,435 | 1,926,371 | 2,320,587 | 1,655,986 | 1,161,359 | 1,646,476 | 4,040,816 | 1,288,820 | 281,002 | 569,867 | 193,028 | 44,517 | 1,097,410 | 585,004 | 558,867 | 121,503 | |||||||
| total current liabilities | 113,007,000 | 111,649,000 | 120,678,000 | 105,395,000 | 92,318,000 | 79,566,000 | 76,063,000 | 57,806,000 | 52,503,000 | 56,709,000 | 57,588,000 | 44,681,000 | 22,488,000 | 22,938,000 | 27,063,000 | 20,614,000 | 16,135,000 | 14,436,000 | 22,756,287 | 18,231,949 | 20,210,375 | 17,635,513 | 24,098,742 | 17,982,321 | 14,151,529 | 9,026,115 | 9,511,354 | 3,468,434 | 3,082,028 | 2,731,394 | 4,266,162 | 2,737,594 | 2,094,535 | 3,440,603 | 5,855,026 | 2,139,609 | 1,646,665 | 833,801 | 298,961 | 294,152 | 1,430,117 | 1,220,637 | 740,143 | 438,081 | 405,054 | 418,496 | 524,346 | 686,519 | |||
| operating lease liability, net of current portion | 2,572,000 | 2,681,000 | 2,786,000 | 2,889,000 | 2,991,000 | 3,091,000 | 3,188,000 | 3,282,000 | 3,376,000 | 3,468,000 | 3,557,000 | 3,643,000 | 3,729,000 | 3,813,000 | 3,894,000 | 3,973,000 | 4,051,000 | 4,129,000 | 568,421 | 647,532 | 725,700 | 801,264 | 875,098 | ||||||||||||||||||||||||||||
| other non-current liabilities | 309,000 | 259,000 | 315,000 | 2,785,000 | 2,396,000 | 2,607,000 | 2,982,000 | 3,575,000 | 12,723,000 | 13,389,000 | 14,064,000 | 14,749,000 | |||||||||||||||||||||||||||||||||||||||
| total liabilities | 115,888,000 | 114,589,000 | 123,779,000 | 111,069,000 | 97,705,000 | 85,264,000 | 82,233,000 | 64,663,000 | 68,602,000 | 73,566,000 | 75,209,000 | 63,073,000 | 26,217,000 | 26,751,000 | 30,957,000 | 24,587,000 | 20,186,000 | 18,565,000 | 22,756,287 | 18,231,949 | 20,210,375 | 18,203,934 | 24,746,274 | 18,708,021 | 14,952,793 | 9,901,213 | 9,666,153 | 3,633,215 | 3,225,363 | 2,881,789 | 4,423,618 | 2,902,110 | 2,397,923 | 4,625,259 | 8,665,756 | 3,978,302 | 2,167,130 | 2,488,559 | 313,709 | 348,522 | 1,472,753 | 1,266,383 | 788,863 | 489,134 | 772,846 | ||||||
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at june 30, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 122,000 | 122,000 | 121,000 | 119,000 | 119,000 | 118,000 | 107,000 | 107,000 | 107,000 | 106,000 | 105,000 | 104,000 | 103,000 | 103,000 | 103,000 | 103,000 | 103,000 | 104,000 | 103,782 | 103,648 | 103,422 | 103,409 | 103,397 | 103,041 | 102,929 | 102,804 | 102,739 | 102,689 | 102,599 | 102,586 | 102,549 | 85,235 | 82,972 | 82,851 | 69,119 | 54,133 | 41,421 | 24,701 | 19,395 | 18,038 | 14,060 | 14,060 | 12,567 | 12,567 | 12,528 | 12,528 | 12,528 | 7,029 | |||
| additional paid-in capital | 461,868,000 | 452,280,000 | 442,286,000 | 431,597,000 | 423,195,000 | 416,747,000 | 266,488,000 | 261,998,000 | 257,976,000 | 254,114,000 | 250,430,000 | 245,514,000 | 239,476,000 | 236,191,000 | 233,186,000 | 231,165,000 | 226,699,000 | 224,927,000 | 223,168,149 | 221,673,450 | 219,581,816 | 217,751,166 | 216,205,678 | 214,478,406 | 213,405,396 | 212,287,975 | 211,265,279 | 210,084,209 | 209,221,591 | 208,426,045 | 207,421,710 | 152,816,719 | 147,374,028 | 145,469,078 | 105,015,871 | 75,670,718 | 56,759,697 | 41,838,614 | 37,209,939 | 35,305,054 | 31,009,459 | 30,783,068 | 26,593,499 | 26,470,291 | 26,129,676 | 26,035,194 | 25,852,961 | 7,836,354 | |||
| retained earnings | 394,006,000 | 341,898,000 | 285,161,000 | 229,225,000 | 185,341,000 | 144,547,000 | 121,272,000 | 86,428,000 | 117,192,000 | 79,430,000 | 49,862,000 | 24,391,000 | 1,643,000 | ||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | 31,000 | -17,000 | 64,000 | 14,000 | 15,000 | 19,000 | 11,000 | 24,000 | 32,000 | -130,000 | -453,000 | -148,000 | -63,000 | -37,000 | -45,000 | 31,332 | -6,471 | -1,191 | 83,751 | 9,505 | 19,428 | 21,758 | |||||||||||||||||||||||||||||
| total stockholders’ equity | 856,027,000 | 794,283,000 | 727,632,000 | 660,941,000 | 608,655,000 | 561,412,000 | 387,881,000 | 348,548,000 | 375,294,000 | 333,661,000 | 300,421,000 | 270,041,000 | 241,092,000 | 220,221,000 | 206,831,000 | 198,661,000 | 188,944,000 | 178,651,000 | 169,597,639 | 156,627,872 | 111,201,425 | 99,675,717 | 87,629,956 | 77,982,538 | 63,281,567 | 51,175,627 | 50,783,809 | 64,076,598 | 71,062,213 | 76,246,466 | 80,963,812 | 31,729,205 | 39,308,930 | 55,476,311 | 35,242,330 | 21,391,252 | 14,622,115 | 3,760,698 | 5,517,779 | 7,617,860 | 10,560,215 | 14,081,574 | 12,745,872 | 15,000,104 | 17,188,435 | 17,828,300 | 18,854,197 | 2,825,488 | |||
| total liabilities and stockholders’ equity | 971,915,000 | 908,872,000 | 851,411,000 | 772,010,000 | 706,360,000 | 646,676,000 | 470,114,000 | 413,211,000 | 443,896,000 | 407,227,000 | 375,630,000 | 333,114,000 | 267,309,000 | 246,972,000 | 237,788,000 | 223,248,000 | 209,130,000 | 197,216,000 | 192,353,926 | 174,859,821 | 131,411,800 | 117,879,651 | 112,376,230 | 96,690,559 | 78,234,360 | 61,076,840 | 60,449,962 | 67,709,813 | 74,287,576 | 79,128,255 | 85,387,430 | 34,631,315 | 41,706,853 | 60,101,570 | 43,908,086 | 25,369,554 | 16,789,245 | 6,249,257 | 5,831,488 | 7,966,382 | 12,032,968 | 15,347,957 | 13,534,735 | 15,489,238 | 17,593,489 | 18,246,796 | 19,378,543 | 3,512,007 | |||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at march 31, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2024 and 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at september 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at june 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at march 31, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2023 and 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at september 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at june 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at march 31, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| short-term investments | 9,876,000 | 19,424,000 | 19,821,000 | 19,956,000 | 19,980,000 | 15,971,000 | 10,041,068 | 10,002,749 | 5,007,050 | 31,561,673 | 36,503,442 | 26,551,064 | 36,922,213 | 51,047,842 | 58,520,956 | 58,342,578 | 26,516,711 | 26,577,501 | 26,512,753 | 26,444,150 | 26,462,962 | 17,483,062 | 7,504,444 | ||||||||||||||||||||||||||||
| deposits | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 8,888 | 10,511 | 10,511 | 21,436 | 25,448 | 25,448 | 25,448 | |||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2022 and 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at september 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at june 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at march 31, 2022 and december 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated deficit | -15,620,000 | -26,310,000 | -32,544,000 | -37,821,000 | -46,335,000 | -53,705,624 | -65,142,755 | -108,482,622 | -118,262,609 | -128,688,624 | -136,618,337 | -150,248,516 | -161,208,464 | -160,563,961 | -146,064,352 | -138,225,479 | -132,260,339 | -126,560,447 | -121,172,749 | -108,148,070 | -90,075,618 | -69,842,660 | -8,219,422 | -7,011,292 | -5,017,973 | ||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2021 and 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at september 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at june 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at march 31, 2021 and december 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2020 and 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at september 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at june 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at march 31, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| investments | 5,008,800 | 5,008,400 | 4,991,600 | 5,008,243 | 5,018,857 | 5,005,321 | |||||||||||||||||||||||||||||||||||||||||||||
| accrued expenses and other liabilities, non-current | 154,799 | 164,781 | 143,335 | 150,395 | 157,456 | 164,516 | 181,162 | 176,293 | 15,839 | 19,131 | 21,878 | 9,518 | 14,748 | 54,370 | 42,636 | 45,746 | 48,720 | 51,053 | |||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2019 and 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at september 30, 2019 and december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at june 30, 2019 and december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at march 31, 2019 and december 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -6,688 | -20,248 | -45,948 | -36,498 | -21,826 | ||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2018 and 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at september 30, 2018 and december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at june 30, 2018 and december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at march 31, 2018 and december 31, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| warrants liability, at fair value | 122,226 | 1,008,363 | 2,794,891 | 1,819,562 | 498,587 | 1,645,240 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2017 and 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at september 30, 2017 and december 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| certificates of deposit | 3,717,229 | 3,715,383 | 4,011,576 | 6,502,825 | |||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2016 and 2015 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| 3. | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2015 and 2014 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2014 and 2013 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| prepaid expenses | 1,609,442 | 1,309,470 | 199,116 | 166,221 | 108,147 | 136,374 | 173,319 | 288,318 | 585,185 | 495,831 | 498,166 | 184,805 | 3,225 | ||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2013 and 2012 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| deficit accumulated during the development stage | -54,333,599 | -42,179,003 | -38,102,617 | -31,711,555 | -27,705,232 | -20,463,304 | -16,715,554 | -13,860,194 | -11,482,754 | -8,953,769 | |||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2012 and 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| warrants liability | 1,934,680 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 2. | |||||||||||||||||||||||||||||||||||||||||||||||||||
| government grant receivable | 134,025 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: none issued and outstanding at december 31, 2011 and 2010 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| no shares issued and outstanding at december 31, 2010 and 2009 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| interest receivable | 12,153 | 17,208 | 24,167 | 41,167 | 65,559 | 78,517 | 86,230 | ||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized: no shares issued and outstanding, at december 31, 2009 and 2008 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| series “a”, no shares issued and outstanding, at december 31, 2008 and 2007 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| series “b”, no shares issued and outstanding, at december 31, 2008 and 2007 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .001 par value, 5,000,000 shares authorized: none outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||
| other assets | 20,388 | 20,388 | 20,388 | 13,555 | |||||||||||||||||||||||||||||||||||||||||||||||
| accrued expenses | 175,576 | 272,113 | 211,881 | 268,765 | |||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity | 19,846,633 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .001 par value, 5,000,000 shares authorized, no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||
| balance sheet data: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| working capital | 19,814,976 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| deferred public offering costs | 472,074 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| liabilities and stockholder’s equity | |||||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity preferred stock, .01 par value, 5,000,000 shares authorized, par value 0.001 per share | |||||||||||||||||||||||||||||||||||||||||||||||||||
| series a preferred stock, 70,000 shares outstanding at september 30, 2006 and december 31, 2005 | 70 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| series b preferred stock, 7,644 shares outstanding at september 30, 2006 and no shares outstanding at december 31, 2005 | 8 |
We provide you with 20 years of balance sheets for Catalyst Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Catalyst Pharmaceuticals. Explore the full financial landscape of Catalyst Pharmaceuticals stock with our expertly curated balance sheets.
The information provided in this report about Catalyst Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.